Hawk70 you got caught lying
”Phase 1 need to do it twice” hahaha when Australia is gold standard when it comes to clinical trials. Also phase 1 allows the company to complete both traumatic brain injury and Stroke clinical trial in one saving millions.
3-4 months with Walter Reed and more non dilutive funding coming in and shortly GLP coming up. 10 million market cap and 10 million in funding pretty stupid
Furthermore this is an Acute treatment drug so not a chronic long term treatment hence the safety profiles, efficacy is easily ticked off. Enjoy the coming period ahead and like I said it’s a 70-100 million dollar company on the pharmacological function
Hawk70 you got caught lying ”Phase 1 need to do it twice” hahaha...
Add NYR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.91M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5000 | 6.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.2¢ | 300 | 1 |
View Market Depth
| Last trade - 16.12pm 07/06/2024 (20 minute delay) ? |
|
|||||
|
Last
6.9¢ |
Change
0.000 ( 2.82 %) |
||||
| Open | High | Low | Volume | ||
| 6.9¢ | 6.9¢ | 6.9¢ | 15000 | ||
| Last updated 15.16pm 07/06/2024 ? | |||||
| NYR (ASX) Chart |
Day chart unavailable